These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Single center analysis of mycophenolate mofetil and Neoral/prednisone therapy for prophylaxis of rejection in African-American and Caucasian transplant recipients. Weber M, Ketchum RJ, Sellers M, Aradhye S, Deng S, Grossman R, Shaw L, Naji A, Barker C, Brayman KL. Transplant Proc; 1997 Aug; 29(1-2):338-9. PubMed ID: 9123029 [No Abstract] [Full Text] [Related]
16. Chronic allograft nephropathy: a prospective randomised trial of cyclosporin reduction with or without mycophenolate mofetil. Jain S, Metcalfe M, White SA, Furness PN, Nicholson ML. Transplant Proc; 2001 May; 33(3):2165-6. PubMed ID: 11377488 [No Abstract] [Full Text] [Related]
18. Mycophenolate mofetil, ATG, and cyclosporine in the induction treatment of renal transplant recipients minimizes the incidence of acute rejection episodes. Puig JM, Lloveras J, Fernández-Crespo P, Mir M, Marcas LI, Manresa JM, Masramón J. Transplant Proc; 1998 Aug; 30(5):2226-7. PubMed ID: 9723449 [No Abstract] [Full Text] [Related]
19. Treatment of chronic renal allograft failure by addition of mycophenolate mofetil: single-center experience in 40 patients. Kliem V, Boeck A, Eisenberger U, Petersen R, Radermacher J, Hiss M, Pethig M, Koch KM, Nashan B, Brunkhorst R. Transplant Proc; 1999 Aug; 31(1-2):1312-3. PubMed ID: 10083586 [No Abstract] [Full Text] [Related]